Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewan Pearson

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Genome Medicine|December 2, 2020
Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT studyValborg Gudmundsdottir, Helle Krogh Pedersen, Gianluca Mazzoni, et al.
Cell Reports. Medicine|February 2, 2022
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT studyAgata Wesolowska-Andersen, Caroline A Brorsson, Roberto Bizzotto, et al.
Genome Medicine|July 15, 2025
The dynamics of the gut microbiota in prediabetes during a four-year follow-up among European patients-an IMI-DIRECT prospective studyLiwei Lyu, Yong Fan, Josef Korbinian Vogt, et al.
Human Molecular Genetics|November 26, 2009
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesJohn R B Perry, Michael N Weedon, Claudia Langenberg, et al.
Nature Biotechnology|January 2, 2023
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning modelsRosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina, et al.
Nature Biotechnology|May 2, 2023
Author Correction: Discovery of drug-omics associations in type 2 diabetes with generative deep-learning modelsRosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina, et al.
Cell|May 7, 2026
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasomeMine Koprulu, Karl Smith-Byrne, Brian Richard Ferolito, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Genome Medicine|December 2, 2020
Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT studyValborg Gudmundsdottir, Helle Krogh Pedersen, Gianluca Mazzoni, et al.
Cell Reports. Medicine|February 2, 2022
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT studyAgata Wesolowska-Andersen, Caroline A Brorsson, Roberto Bizzotto, et al.
Genome Medicine|July 15, 2025
The dynamics of the gut microbiota in prediabetes during a four-year follow-up among European patients-an IMI-DIRECT prospective studyLiwei Lyu, Yong Fan, Josef Korbinian Vogt, et al.
Human Molecular Genetics|November 26, 2009
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesJohn R B Perry, Michael N Weedon, Claudia Langenberg, et al.
Nature Biotechnology|January 2, 2023
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning modelsRosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina, et al.
Nature Biotechnology|May 2, 2023
Author Correction: Discovery of drug-omics associations in type 2 diabetes with generative deep-learning modelsRosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina, et al.
Cell|May 7, 2026
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasomeMine Koprulu, Karl Smith-Byrne, Brian Richard Ferolito, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 5